244 related articles for article (PubMed ID: 33593401)
1. Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis.
Reyhan I; Zhukov OS; Lagier RJ; Bridgforth RF; Williams GJ; Popov JM; Naides SJ; Reiff A
Pediatr Rheumatol Online J; 2021 Feb; 19(1):14. PubMed ID: 33593401
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3
Dalrymple A; Tuttle P; Feller L; Zhukov O; Lagier R; Popov J; Naides S; Moore T
Pediatr Rep; 2021 Jan; 13(1):65-71. PubMed ID: 33504004
[TBL] [Abstract][Full Text] [Related]
5. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
Lipinska J; Lipinska S; Kasielski M; Smolewska E
Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
[TBL] [Abstract][Full Text] [Related]
7. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
Brunner J; Sitzmann FC
Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
[TBL] [Abstract][Full Text] [Related]
9. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of 14-3-3η and anti-carbamylated protein antibodies in Rheumatoid Arthritis in Han population of Northern China.
Zhang Y; Liang Y; Feng L; Cui L
Clin Chim Acta; 2020 Mar; 502():102-110. PubMed ID: 31862264
[TBL] [Abstract][Full Text] [Related]
11. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).
Berntson L; Nordal E; Fasth A; Aalto K; Herlin T; Nielsen S; Rygg M; Zak M; Rönnelid J;
Pediatr Rheumatol Online J; 2014; 12():22. PubMed ID: 24944545
[TBL] [Abstract][Full Text] [Related]
12. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
Zhang L; Ru J; Jie X; Che G; Jin X; Li X
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
[TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial).
Omar A; Abo-Elyoun I; Hussein H; Nabih M; Atwa H; Gad S; Emad Y
Joint Bone Spine; 2013 Jan; 80(1):38-43. PubMed ID: 22575064
[TBL] [Abstract][Full Text] [Related]
14. Limitations in the classification of childhood-onset rheumatoid arthritis.
Ferrell EG; Ponder LA; Minor LS; Angeles-Han ST; Kennedy CW; Rouster-Stevens KA; Rohani-Pichavant M; Vogler LB; Prahalad S
J Rheumatol; 2014 Mar; 41(3):547-53. PubMed ID: 24488421
[TBL] [Abstract][Full Text] [Related]
15. A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia.
van Beers-Tas MH; Marotta A; Boers M; Maksymowych WP; van Schaardenburg D
Arthritis Res Ther; 2016 Apr; 18():76. PubMed ID: 27037016
[TBL] [Abstract][Full Text] [Related]
16. Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population.
Kwok JS; Hui KH; Lee TL; Wong W; Lau YL; Wong RW; Kim DL; Jones BM
Scand J Rheumatol; 2005; 34(5):359-66. PubMed ID: 16234183
[TBL] [Abstract][Full Text] [Related]
17. Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.
Maksymowych WP; Naides SJ; Bykerk V; Siminovitch KA; van Schaardenburg D; Boers M; Landewé R; van der Heijde D; Tak PP; Genovese MC; Weinblatt ME; Keystone EC; Zhukov OS; Abolhosn RW; Popov JM; Britsemmer K; van Kuijk AW; Marotta A
J Rheumatol; 2014 Nov; 41(11):2104-13. PubMed ID: 25128504
[TBL] [Abstract][Full Text] [Related]
18. Identification of key biomarkers in RF-negative polyarticular and oligoarticular juvenile idiopathic arthritis by bioinformatic analysis.
Liu Y; Tang X
Pediatr Rheumatol Online J; 2023 Nov; 21(1):143. PubMed ID: 38001449
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.
Fitzpatrick L; Broadaway KA; Ponder L; Angeles-Han ST; Jenkins K; Rouster-Stevens K; Pelajo CF; Conneely K; Epstein MP; Lopez-Benitez J; Vogler LB; Prahalad S;
J Rheumatol; 2016 Apr; 43(4):799-803. PubMed ID: 26879356
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
Habib HM; Mosaad YM; Youssef HM
Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]